These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 32534564)
21. Therapeutic angiogenesis of exosomes for ischemic stroke. Manuel GE; Johnson T; Liu D Int J Physiol Pathophysiol Pharmacol; 2017; 9(6):188-191. PubMed ID: 29348795 [TBL] [Abstract][Full Text] [Related]
22. Design strategies and application progress of therapeutic exosomes. Liu C; Su C Theranostics; 2019; 9(4):1015-1028. PubMed ID: 30867813 [TBL] [Abstract][Full Text] [Related]
23. pH-Sensitive, Cerebral Vasculature-Targeting Hydroxyethyl Starch Functionalized Nanoparticles for Improved Angiogenesis and Neurological Function Recovery in Ischemic Stroke. Yang H; Luo Y; Hu H; Yang S; Li Y; Jin H; Chen S; He Q; Hong C; Wu J; Wan Y; Li M; Li Z; Yang X; Su Y; Zhou Y; Hu B Adv Healthc Mater; 2021 Jun; 10(12):e2100028. PubMed ID: 34028998 [TBL] [Abstract][Full Text] [Related]
24. Engineered Exosomes: A Promising Drug Delivery Strategy for Brain Diseases. Jiang Y; Wang F; Wang K; Zhong Y; Wei X; Wang Q; Zhang H Curr Med Chem; 2022; 29(17):3111-3124. PubMed ID: 34477508 [TBL] [Abstract][Full Text] [Related]
25. Pleiotropic Effects of Exosomes as a Therapy for Stroke Recovery. Ueno Y; Hira K; Miyamoto N; Kijima C; Inaba T; Hattori N Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962207 [TBL] [Abstract][Full Text] [Related]
26. Nanoparticles-mediated emerging approaches for effective treatment of ischemic stroke. He W; Zhang Z; Sha X Biomaterials; 2021 Oct; 277():121111. PubMed ID: 34488117 [TBL] [Abstract][Full Text] [Related]
27. HDAC4 in ischemic stroke: mechanisms and therapeutic potential. Kong Q; Hao Y; Li X; Wang X; Ji B; Wu Y Clin Epigenetics; 2018 Sep; 10(1):117. PubMed ID: 30208931 [TBL] [Abstract][Full Text] [Related]
29. Novel brain-targeting 3-n-butylphthalide prodrugs for ischemic stroke treatment. Xiang H; Zhang Q; Han Y; Yang L; Zhang Y; Liu Q; Zhang Z; Zhang L J Control Release; 2021 Jul; 335():498-514. PubMed ID: 34087248 [TBL] [Abstract][Full Text] [Related]
30. Techniques and Applications of Animal- and Plant-Derived Exosome-Based Drug Delivery System. Man F; Wang J; Lu R J Biomed Nanotechnol; 2020 Nov; 16(11):1543-1569. PubMed ID: 33461649 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic effects of lipo-prostaglandin E1 on angiogenesis and neurogenesis after ischemic stroke in rats. Ling L; Zhang S; Ji Z; Huang H; Yao G; Wang M; He R; Deng W; Fang L Int J Neurosci; 2016; 126(5):469-77. PubMed ID: 26000823 [TBL] [Abstract][Full Text] [Related]
32. Exosomes as Carriers for Drug Delivery in Cancer Therapy. Zeng W; Wen Z; Chen H; Duan Y Pharm Res; 2023 Apr; 40(4):873-887. PubMed ID: 35352281 [TBL] [Abstract][Full Text] [Related]
33. Exosome-Based Delivery of Natural Products in Cancer Therapy. Song H; Liu B; Dong B; Xu J; Zhou H; Na S; Liu Y; Pan Y; Chen F; Li L; Wang J Front Cell Dev Biol; 2021; 9():650426. PubMed ID: 33738290 [TBL] [Abstract][Full Text] [Related]
34. Exosome-mediated targeted delivery of miR-210 for angiogenic therapy after cerebral ischemia in mice. Zhang H; Wu J; Wu J; Fan Q; Zhou J; Wu J; Liu S; Zang J; Ye J; Xiao M; Tian T; Gao J J Nanobiotechnology; 2019 Feb; 17(1):29. PubMed ID: 30782171 [TBL] [Abstract][Full Text] [Related]
35. Exosome: a significant nano-scale drug delivery carrier. Peng H; Ji W; Zhao R; Yang J; Lu Z; Li Y; Zhang X J Mater Chem B; 2020 Sep; 8(34):7591-7608. PubMed ID: 32697267 [TBL] [Abstract][Full Text] [Related]
36. Pathophysiology of Ischemic Stroke: Role of Oxidative Stress. Orellana-Urzúa S; Rojas I; Líbano L; Rodrigo R Curr Pharm Des; 2020; 26(34):4246-4260. PubMed ID: 32640953 [TBL] [Abstract][Full Text] [Related]
37. Comparison of two endogenous delivery agents in cancer therapy: Exosomes and ferritin. Li L; Zhang L; Knez M Pharmacol Res; 2016 Aug; 110():1-9. PubMed ID: 27157249 [TBL] [Abstract][Full Text] [Related]
38. Utility of Exosomes in Ischemic and Hemorrhagic Stroke Diagnosis and Treatment. Lee EC; Ha TW; Lee DH; Hong DY; Park SW; Lee JY; Lee MR; Oh JS Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955498 [TBL] [Abstract][Full Text] [Related]
39. Tissue plasminogen activator-based nanothrombolysis for ischemic stroke. Liu S; Feng X; Jin R; Li G Expert Opin Drug Deliv; 2018 Feb; 15(2):173-184. PubMed ID: 28944694 [TBL] [Abstract][Full Text] [Related]
40. [Construction of engineered exosomes with high loading efficiency of cellular endogenous proteins]. Huang L; Wang D; Gu N; Zhang XE Sheng Wu Gong Cheng Xue Bao; 2019 Aug; 35(8):1537-1545. PubMed ID: 31441625 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]